Posted inBusiness
Dr. Reddy’s Delays Semaglutide Rollout Following Quality Control Concerns
Dr. Reddy's halts semaglutide launch due to quality concerns, impacting shares and the race for generic weight-loss and diabetes treatments.
Posted inBusiness
Medicare Expands Coverage to Include GLP-1 Drugs for Weight Loss
New Policy Marks Shift in Medicare CoverageIn a significant policy shift, Medicare has announced it will now provide coverage for GLP-1 receptor agonists prescribed specifically for weight management, setting a…
